Ask AI
ProCE Banner Activity

ART Selection in Pregnancy

Clinical Thought

What would you do for a patient with HIV who is 28 weeks pregnant and has a history of adherence challenges with oral ART? Emerging evidence suggests that long-acting injectable ART is one safe and highly effective option in pregnant people, but what other factors should be considered before initiating treatment? Read on to find out what I would do in this situation and why.

Released: July 23, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc., in partnership with the Goldschmidt Collective.

Gilead Sciences, Inc.

Partners

Goldschmidt Collective

ProCE Banner

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals (HCPs) who provide care for people living with HIV in specialist or primary care settings.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select an appropriately individualized ART regimen for each person living with HIV when initiating therapy or modifying a virologically suppressive regimen

  • Tailor ART regimens to optimize patient satisfaction and outcomes among people living with HIV who have common comorbidities and comedications

Financial Disclosures

Primary Author

Carolyn Chu, MD, MSc, FAAFP, AAHIVS, has no relevant financial relationships to disclose.